| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Director | Jun 5, 2024 | |||
| RETA | REATA PHARMACEUTICALS INC | EVP, Chief R&D Officer | Sep 26, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|